[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@OncNewsCentral Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::615435338.png) @OncNewsCentral Oncology News Central

Oncology News Central posts on X about drugs, $490k, $90k, ranks the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::615435338/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::615435338/c:line/m:interactions.svg)

- X Month XXX +28%
- X Months XXXXX -XX%
- X Year XXXXXX +105%

### Mentions: X [#](/creator/twitter::615435338/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::615435338/c:line/m:posts_active.svg)

- X Month X +20%
- X Months XX -XX%
- X Year XXX +122%

### Followers: XXXXX [#](/creator/twitter::615435338/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::615435338/c:line/m:followers.svg)

- X Month XXXXX +2.20%
- X Months XXXXX +12%
- X Year XXXXX +24%

### CreatorRank: undefined [#](/creator/twitter::615435338/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::615435338/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::615435338/influence)
---

**Social topic influence**
[drugs](/topic/drugs), [$490k](/topic/$490k), [$90k](/topic/$90k), [ranks](/topic/ranks), [90k](/topic/90k), [breast cancer](/topic/breast-cancer)
### Top Social Posts [#](/creator/twitter::615435338/posts)
---
Top posts by engagements in the last XX hours

"A timely read for oncology professionals: GLP-1 drugs are everywhere but what do they mean for cancer care #Oncology #CancerCare #GLP1"  
[X Link](https://x.com/OncNewsCentral/status/1978122906518396961) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-14T15:37Z 1998 followers, XX engagements


"Radiopharmaceutical therapy for prostate cancer is a hot topic now says @UCLAHealth's @CalaisJeremie. He spoke with @OncNewsCentral about which findings at #ESMO25 (@myESMO) are most anticipated: #ProstateCancer"  
[X Link](https://x.com/OncNewsCentral/status/1979151934444445914) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-17T11:46Z 1998 followers, XX engagements


"Starting salaries for oncologists have hit $490K in 2025 up nearly $90K since 2021. Oncology now ranks as the most in-demand specialty according to @AMNHealthcare. 🔗"  
[X Link](https://x.com/OncNewsCentral/status/1979188944827740294) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-17T14:13Z 1997 followers, XX engagements


"Imlunestrant is now FDA-approved for ESR1-mutated ER+ HER2 advanced disease. Learn how this new therapy is changing the treatment landscape: #BreastCancerAwarenessMonth"  
[X Link](https://x.com/OncNewsCentral/status/1978810433801707796) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-16T13:09Z 1999 followers, XX engagements


"Whats next after T-DXd in metastatic breast cancer Real-world data published in @JNCI_Now show limited durability with follow-up therapies and wide variation by subtype. 🔗 #BreastCancer"  
[X Link](https://x.com/OncNewsCentral/status/1979191693472665966) [@OncNewsCentral](/creator/x/OncNewsCentral) 2025-10-17T14:24Z 1998 followers, XX engagements